Limitations of Non-GAAP Measures
There are a number of limitations related to EBITDA, including the following:
- EBITDA excludes certain recurring, non-cash charges, such as depreciation of property and equipment and/or amortization of intangible assets. While these are non-cash charges, we may need to replace the assets being depreciated and amortized in the future and EBITDA does not reflect cash requirements for these replacements or new capital expenditure requirements.
- EBITDA does not reflect interest expense, net, which may constitute a significant recurring expense in the future.
- Free cash flow does not reflect the impact of equity or debt raises or repayment of debt or dividends paid.
Because of these and other limitations, EBITDA and Free cash flow should not be considered in isolation or as a substitute for performance measures calculated in accordance with GAAP. We compensate for these limitations by relying primarily on our GAAP results and using EBITDA and Free cash flow on a supplemental basis. You should review the reconciliation of our net loss to EBITDA and net loss to Free cash flow below and not rely on any single financial measure to evaluate our business.
Our presentation of EBITDA should not be construed as an inference that our future results will be unaffected by unusual or non-recurring items and our presentation of Free cash flow does not necessarily indicate whether cash flows will be sufficient to fund our cash needs.
Reconciliation
The following table reconciles our net loss (the most directly comparable GAAP measure to EBITDA) to EBITDA for the period presented:
|
|
Three Months Ended
|
||||||
|
|
2023 |
|
2022 |
||||
Net loss |
|
$ |
(4,767,517 |
) |
|
$ |
(2,287,794 |
) |
Interest (income) expense, net |
|
|
(32,427 |
) |
|
|
(582 |
) |
Income tax expense |
|
|
— |
|
|
|
— |
|
Depreciation and amortization |
|
|
126,115 |
|
|
|
135,153 |
|
EBITDA |
|
$ |
(4,673,829 |
) |
|
$ |
(2,153,223 |
) |
The following table reconciles our net cash used in operating activities (the most directly comparable GAAP measure to Free Cash Flow) to Free cash flow for the periods presented:
|
|
Three Months Ended
|
||||||
|
|
2023 |
|
2022 |
||||
Net cash used in operating activities |
|
$ |
(4,050,573 |
) |
|
$ |
(1,903,217 |
) |
Capital expenditures |
|
|
(344,801 |
) |
|
|
(102,381 |
) |
Free cash flow |
|
$ |
(4,395,374 |
) |
|
$ |
(2,005,598 |
) |